A bioinspired redox-modulating copper(<scp>ii</scp>)–macrocyclic complex bearing non-steroidal anti-inflammatory drugs with anti-cancer stem cell activity-Reference-Cited by-同舟云学术

A bioinspired redox-modulating copper(ii)–macrocyclic complex bearing non-steroidal anti-inflammatory drugs with anti-cancer stem cell activity

Published:2022 Issue:15 Volume:51 Page:5904-5912
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Johnson Alice¹^ORCID,Iffland-Mühlhaus Linda²,Northcote-Smith Joshua¹,Singh Kuldip¹,Ortu Fabrizio¹^ORCID,Apfel Ulf-Peter²³^ORCID,Suntharalingam Kogularamanan¹^ORCID

Affiliation:

1. School of Chemistry, University of Leicester, Leicester, LE1 7RH, UK

2. Ruhr-Universität Bochum, Anorganische Chemie I, Universitätsstraße 150, 44801 Bochum, Germany

3. Fraunhofer UMSICHT, Osterfelder Str. 3, 46047 Oberhausen, Germany

Abstract

Here we report a biologically stable copper(ii) complex based on the active site of Type I Cu electron transport proteins.

Funder

Engineering and Physical Sciences Research Council

Deutsche Forschungsgemeinschaft

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/DT/D2DT00788F

Reference55 articles.

1. Tumour heterogeneity and cancer cell plasticity

2. The causes and consequences of genetic heterogeneity in cancer evolution

3. Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicine

4. Cancer stem cells

5. Cancer stem cells as key drivers of tumour progression

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cobalt(III) prodrug-based nanomedicine for inducing immunogenic cell death and enhancing chemo-immunotherapy;Journal of Controlled Release;2024-09

2. Unleashing the binding interaction of chrysin-Cu(II) complex with the biomacromolecular targets: further studies of cell cytotoxicity and radical scavenging properties;Journal of Biomolecular Structure and Dynamics;2024-01-08

3. Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co(ii), Cu(ii) and Zn(ii)] tailored anticancer chemotherapeutic agents against resistant cancer cells;Dalton Transactions;2024

4. Synthesis, characterization and biological evaluation of three novel copper(II) clonixinate complexes with methylpyridines: Insights into structure, DNA and BSA binding properties and anticancer activity;Polyhedron;2023-11

5. The Anti-Breast Cancer Stem Cell Potency of Copper(I)-Non-Steroidal Anti-Inflammatory Drug Complexes;Molecules;2023-09-01